Executive nurse leader and nurse practitioner work together

Amrita Datta

Assistant Professor
LOY-Placeholder Image
Career Highlights
  • 12+ years of research experience; 13 publications in high ranked journals
  • 10+ years as an educator at graduate and undergraduate level (MS, PhD., MD students)
  • Teaches undergraduate and graduate level Pathophysiology and Pharmacology at Loyola and Principles of Pharmacology and Medical Pharmacotherapeutics at Tulane.

Dr. Datta joins the adjunct faculty at Loyola with an extensive career in research and teaching and a desire to push advancements in cancer diagnostics and treatments forward. Dr. Datta’s research focus includes role of vesicle biology, particularly exosomes in Cancer, Single Nucleotide Polymorphisms as Cancer Biomarkers. She is currently working on a NIH/NCATS funded grant investigating drug repositioning and inhibitors of exosomes in Prostate Cancer.

Dr. Datta received her Bachelors of Engineering in Biotechnology from India. Thereafter she decided to further her education at Tulane University in New Orleans and received her PhD in Pharmacology in 2013. Between 2007 and 2013 she served as teaching assistant to Departments of Molecular Biology and Pharmacology. She was then selected to be a fellow at Tulane Urology where she continues her research in the field of Cancer and teaches and mentors Masters, Doctorate and MD students.

In the past Dr. Datta has co-written and won funding for BMAP3, a developmental project grant: Minority Biospecimen/Biobanking Geographic Management Program for Region 3 to study Sox9 and FAK expression as indicators of aggressive breast cancer in African American women and written and received funding for the Tulane Cancer Center’s Matching Funds grant.

Dr. Datta reviews manuscripts regularly for Cancer Letters (Elsevier), Scientific Reports (Nature Publishing Group) and Prostate Cancer and Prostatic Diseases (Nature Publishing Group), Cancer (ACS), Journal of Cell Dearth, Gene Regulations and Systems Biology, Clinical Medicine Insights: Therapeutics, Drug Target Insights and Cancer Growth and Metastasis (LA). She is currently working as an editor for Intech Publishing on a book titled “Current protocols in Molecular Biology”.

Dr. Datta is the 2015 recipient of the Cold Spring Harbor Laboratory’s Helmsley Scholarship for interdisciplinary scientists.

Teaching is a privilege. Through research and education we are able to enrich the society and equip it with future researchers and educators. We pass on our knowledge to those who will go onto help and serve others. Our profession allows us to serve both God and Science for generations.

Courses Taught

Nurs G805 Advanced Pathophysiology
Nurs G820 Advanced Pharmacotherapeutics

Published Works

Moustafa AA, Ziada M, Elshaikh A, Datta A, Kim H, Moroz K, Srivastav S, Thomas R, Silberstein JL, Moparty K, Salem FE, El-Habit OH, Abdel-Mageed AB. Identification of microRNA signature and potential pathway targets in prostate cancer. Exp Biol Med (Maywood). 2016 Nov 29. pii: 1535370216681554. [Epub ahead of print] PubMed PMID: 27903835.

Sangkum P, Yafi FA, Kim H, Bouljihad M, Ranjan M, Datta A, Mandava SH, Sikka SC, Abdel-Mageed AB, Hellstrom WJ. Effect of adipose tissue-derived stem cell injection in a rat model of urethral fibrosis. Can Urol Assoc J. 2016 May-Jun;10(5-6):E175-E180. PubMed PMID: 27790299; PubMed Central PMCID: PMC5065407.

Kim H, Datta A, Talwar S, Saleem SN, Mondal D, Abdel-Mageed AB. Estradiol-ERβ2 signaling axis confers growth and migration of CRPC cells through TMPRSS2-ETV5 gene fusion. Oncotarget. 2016 Aug 17. doi: 10.18632/oncotarget.11355. [Epub ahead of print] PubMed PMID: 27542225.

Liu J, Abshire C, Carry C, Sholl AB, Mandava SH, Datta A, Ranjan M, Callaghan C, Peralta DV, Williams KS, Lai WR, Abdel-Mageed AB, Tarr M, Lee BR. Nanotechnology combined therapy: tyrosine kinase-bound gold nanorod and laser thermal ablation produce a synergistic higher treatment response of renal cell carcinoma in a murine model. BJU Int. 2017 Feb;119(2):342-348. doi: 10.1111/bju.13590. PubMed PMID: 27431021.

Chakravarty G, Mathur A, Mallade P, Gerlach S, Willis J, Datta A, Srivastav S, Abdel-Mageed AB, Mondal D. Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells. Biochimie. 2016 May;124:53-64. doi: 10.1016/j.biochi.2016.01.014. PubMed PMID: 26844637.

Yang Y, Jia D, Kim H, Abd Elmageed ZY, Datta A, Davis R, Srivastav S, Moroz K, Crawford BE, Moparty K, Thomas R, Hudson RS, Ambs S, Abdel-Mageed AB. Dysregulation of miR-212 Promotes Castration Resistance through hnRNPH1-Mediated Regulation of AR and AR-V7: Implications for Racial Disparity of Prostate Cancer. Clin Cancer Res. 2016 Apr 1;22(7):1744-56. doi: 10.1158/1078-0432.CCR-15-1606. PubMed PMID: 26553749.

Sangkum P, Yafi FA, Kim H, Bouljihad M, Ranjan M, Datta A, Mandava SH, Sikka SC, Abdel-Mageed AB, Moparty K, Hellstrom WJ. Collagenase Clostridium histolyticum (Xiaflex) for the Treatment of Urethral Stricture Disease in a Rat Model of Urethral Fibrosis. Urology. 2015 Sep;86(3):647.e1-6. doi: 10.1016/j.urology.2015.06.013. PubMed PMID: 26126692; PubMed Central PMCID: PMC4914046.

Datta A, Bhasin N, Kim H, Ranjan M, Rider B, Abd Elmageed ZY, Mondal D, Agrawal KC, Abdel-Mageed AB. Selective targeting of FAK-Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells. Cancer Lett. 2015 Jun 28;362(1):25-35. doi: 10.1016/j.canlet.2015.03.009. PubMed PMID: 25796439.

Schultz MA, Hagan SS, Datta A, Zhang Y, Freeman ML, Sikka SC, Abdel-Mageed AB, Mondal D. Nrf1 and Nrf2 transcription factors regulate androgen receptor transactivation in prostate cancer cells. PLoS One. 2014 Jan 22;9(1):e87204. doi:
1371/journal.pone.0087204. PubMed PMID: 24466341; PubMed Central PMCID: PMC3899380.

Education

PhD in Pharmacology, Tulane University Health Sciences Center
B. Tech, Biotechnology, Jaypee Institute of Information Technology